MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from pipe, net of
issuance costs
$126,421K
Proceeds from issuance of
common stock and espp
$202K
Net cash provided by
financing activities
$126,623K
Net decrease in
cash, cash...
-$11,254K
Canceled cashflow
$126,623K
Sale of fixed
maturity securities,...
$28,660K
Depreciation
$3,004K
Stock based
compensation
$1,445K
Non-cash operating lease
expense (benefit)
$412K
Net cash provided
(used in) by investing...
-$112,615K
Canceled cashflow
$28,660K
Net cash used in
operating activities
-$25,262K
Canceled cashflow
$4,861K
Acquisition of fixed
maturity securities,...
$140,691K
Acquisition of property and
equipment
$584K
Net income (loss)
-$21,645K
Accrued expenses and
other liabilities
-$3,956K
Change in fair value of
contingent liabilities
$1,818K
Accounts payable
-$1,625K
Operating lease liability
-$786K
Accretion of investments
$211K
Prepaid expenses and
other assets
$62K
Security deposit
-$20K
Back
Back
Cash Flow
Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. (IPSC)
source: myfinsight.com